Skip to main content
Journal cover image

Staging non-small cell carcinoma of the lung using technetium-99m-labeled monoclonal antibodies.

Publication ,  Journal Article
Friedman, S; Sullivan, K; Salk, D; Nelp, WB; Griep, RJ; Johnson, DH; Blend, MJ; Aye, R; Suppers, V; Abrams, PG
Published in: Hematol Oncol Clin North Am
December 1990

A technetium-labeled monoclonal antibody was administered to 52 patients with non-small cell lung carcinoma, either to stage the mediastinum preoperatively or to detect distant metastases. Results from planar and tomographic imaging are compared to CT and histologic confirmation. Differences in detection rates and predictive values between imaging modalities are discussed. The authors conclude that imaging with a technetium-labeled monoclonal antibody is safe and accurate and may be useful for staging patients with either operable or inoperable non-small cell lung cancer.

Duke Scholars

Published In

Hematol Oncol Clin North Am

ISSN

0889-8588

Publication Date

December 1990

Volume

4

Issue

6

Start / End Page

1069 / 1078

Location

United States

Related Subject Headings

  • Tomography, Emission-Computed, Single-Photon
  • Technetium
  • Reagent Kits, Diagnostic
  • Preoperative Care
  • Pilot Projects
  • Organ Specificity
  • Oncology & Carcinogenesis
  • Neoplasm Staging
  • Neoplasm Metastasis
  • Mediastinum
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Friedman, S., Sullivan, K., Salk, D., Nelp, W. B., Griep, R. J., Johnson, D. H., … Abrams, P. G. (1990). Staging non-small cell carcinoma of the lung using technetium-99m-labeled monoclonal antibodies. Hematol Oncol Clin North Am, 4(6), 1069–1078.
Friedman, S., K. Sullivan, D. Salk, W. B. Nelp, R. J. Griep, D. H. Johnson, M. J. Blend, R. Aye, V. Suppers, and P. G. Abrams. “Staging non-small cell carcinoma of the lung using technetium-99m-labeled monoclonal antibodies.Hematol Oncol Clin North Am 4, no. 6 (December 1990): 1069–78.
Friedman S, Sullivan K, Salk D, Nelp WB, Griep RJ, Johnson DH, et al. Staging non-small cell carcinoma of the lung using technetium-99m-labeled monoclonal antibodies. Hematol Oncol Clin North Am. 1990 Dec;4(6):1069–78.
Friedman, S., et al. “Staging non-small cell carcinoma of the lung using technetium-99m-labeled monoclonal antibodies.Hematol Oncol Clin North Am, vol. 4, no. 6, Dec. 1990, pp. 1069–78.
Friedman S, Sullivan K, Salk D, Nelp WB, Griep RJ, Johnson DH, Blend MJ, Aye R, Suppers V, Abrams PG. Staging non-small cell carcinoma of the lung using technetium-99m-labeled monoclonal antibodies. Hematol Oncol Clin North Am. 1990 Dec;4(6):1069–1078.
Journal cover image

Published In

Hematol Oncol Clin North Am

ISSN

0889-8588

Publication Date

December 1990

Volume

4

Issue

6

Start / End Page

1069 / 1078

Location

United States

Related Subject Headings

  • Tomography, Emission-Computed, Single-Photon
  • Technetium
  • Reagent Kits, Diagnostic
  • Preoperative Care
  • Pilot Projects
  • Organ Specificity
  • Oncology & Carcinogenesis
  • Neoplasm Staging
  • Neoplasm Metastasis
  • Mediastinum